Borders-based specialty pharmaceutical company, Kyowa Kirin International plc (KKI), hosted Dr. Nobuo Hanai, President and Chief Executive Officer of KKI’s parent company, Kyowa Hakko Kirin Co. Ltd., at the company’s head office in Galashiels this week.
Dr. Hanai was on an annual visit to KKI to meet with staff and was able to see for himself progress on the expansion of KKI’s international headquarters.
KKI has acquired a 10 year lease on the 10,000 square feet building adjacent to its existing head office in Galashiels Business Park and, once construction work is completed in the second half of this year, will occupy a headquarters facility of 35,000 square feet – an increase of 40% over its current facility.
Dr. Hanai said:
“This opportunity was very important for me to have an interaction with our people in KKI and I am very pleased that they are making every effort to develop KKI’s business through the expansion of its headquarters office.”
Dr. Stratford, said:
“We are proud of what the team at KKI has achieved as part of the Kyowa Hakko Kirin group of companies and we are delighted that Dr. Hanai has gone to such trouble to visit us here in Scotland.”
“Construction work for our new headquarters facility is well under way and, as we continue to grow the KKI business, will provide welcome additional accommodation for our growing team here in Galashiels.”